Leah N. Woosley

Echinocandin and Triazole Antifungal Susceptibility Profiles for Clinical Opportunistic Yeast and Mold Isolates Collected from 2010 to 2011: Application of New CLSI Clinical Breakpoints and Epidemiological Cutoff Values for Characterization of Geographic and Temporal Trends of Antifungal Resistance

Michael A. Pfaller, S. A. Messer, Leah N. Woosley et al. · Journal of Clinical Microbiology · 2013 · 237 citations · Full text

Life Sciences, Infectious Diseases, Microbiology +17

Low Prevalence of <i>fks1</i> Hot Spot 1 Mutations in a Worldwide Collection of <i>Candida</i> Strains

Mariana Castanheira, Leah N. Woosley, Daniel J. Diekema et al. · Antimicrobial Agents and Chemotherapy · 2010 · 126 citations

Life Sciences, Molecular Biology, Molecular Genetics +16

Candida guilliermondii and Other Species of Candida Misidentified as Candida famata: Assessment by Vitek 2, DNA Sequencing Analysis, and Matrix-Assisted Laser Desorption Ionization–Time of Flight Mass Spectrometry in Two Global Antifungal Surveillance Programs

Mariana Castanheira, Leah N. Woosley, Daniel J. Diekema et al. · Journal of Clinical Microbiology · 2012 · 97 citations · Full text

Life Sciences, Biology, Microbiology +17

<i>In Vitro</i> Activity of Delafloxacin and Microbiological Response against Fluoroquinolone-Susceptible and Nonsusceptible Staphylococcus aureus Isolates from Two Phase 3 Studies of Acute Bacterial Skin and Skin Structure Infections

Sandra P. McCurdy, Laura Lawrence, Manuel Rodrigues Quintas et al. · Antimicrobial Agents and Chemotherapy · 2017 · 85 citations · Full text

Life Sciences, Infectious Diseases, Microbiology +17

Significance of Molecular Identification and Antifungal Susceptibility of Clinically Significant Yeasts and Moulds in a Global Antifungal Surveillance Programme

Michael A. Pfaller, Leah N. Woosley, S. A. Messer et al. · Mycopathologia · 2012 · 82 citations

Life Sciences, Infectious Diseases, Microbiology +17